Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area others cam kinase ii'

Search results for: 'research area others cam kinase ii'

Items 51-60 of 87

Page
per page
  1. TG101348 (SAR302503)
    A4136 TG101348 (SAR302503)
     2 Citation
    Target: FLT3|JAK|c-RET
    Summary: JAK-2 inhibitor,potent and selective
      ≥26.23 mg/mL
  2. Phthalazinone pyrazole
    C3823 Phthalazinone pyrazole
    Summary: Aurora A kinase inhibitor
      insoluble in EtOH; insoluble in H2O; ≥7.14 mg/mL
  3. CYT387
    A4143 CYT387
     1 Citation
    Summary: JAK-1/-2 inhibitor,ATP competitive
      insoluble in EtOH; insoluble in H2O; ≥20.7 mg/mL
  4. Cercosporamide
    A4511 Cercosporamide
    Target: JAK|MNK
    Summary: Mnk2 and JAK3 inhibitor
      soluble in DMSO
  5. Tofacitinib (CP-690550) Citrate
    A4135 Tofacitinib (CP-690550) Citrate
     2 Citation
    Target: JAK
    Summary: Potent JAK inhibitor
      ≥25.22 mg/mL
  6. SMI-4a
    A4193 SMI-4a
    Target: Pim
    Summary: Potent Pim inhibitor
      insoluble in H2O; ≥13.65 mg/mL
  7. PCI-34051
    A4091 PCI-34051
     1 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC8 inhibitor,potent and selective
      insoluble in H2O; insoluble in EtOH; ≥14.8 mg/mL
  8. AZ 960
    A4144 AZ 960
    Target: JAK
    Summary: JAKs inhibitor
      Soluble in DMSO
  9. Tubastatin A HCl
    A8547 Tubastatin A HCl
     1 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC6 inhibitor,potent and selective
      insoluble in EtOH; ≥12.34 mg/mL
  10. WP1066
    A4140 WP1066
    Target: STAT|JAK
    Summary: JAK2/STAT3 inhibitor,cell-permeable
      insoluble in H2O; ≥17.8 mg/mL

Items 51-60 of 87

Page
per page
Shop By
Now Shopping by
  1. Category Chromatin/Epigenetics Remove This Item
Clear All
Shopping Options
Category
  1. Bromodomain 1 item
  2. Aurora Kinase 29item
  3. HDAC 11item
  4. Histone Acetyltransferases 1 item
  5. Histone Methyltransferase 3item
  6. JAK 22item
  7. PARP 1 item
  8. Pim 8item
  9. Protein Ser/Thr Phosphatases 7item
  10. RNA Polymerase 1 item
  11. Sirtuin 1 item
  12. Sphingosine Kinase-2 1 item
  13. Polycomb repressive complex 1 item
Specificity
  1. Selective 29item
Reversibility
  1. Reversible 3item
Target
  1. Cyclin-Dependent Kinases 1 item
  2. Histone Deacetylases (HDACs) 7item
  3. Aurora Kinases 19item
  4. EZH2 1 item
  5. FLT3 4item
  6. PLK 1 item
  7. VEGFR 2item
  8. RET 1 item
  9. MEK 1 item
  10. FGFR 1 item
  11. Pim 3item
  12. Sir2-like Family Deacetylases (Sirtuins) 1 item
  13. PP1 1 item
  14. PP2A 1 item
  15. Src 4item
  16. STAT 1 item
  17. EGFR 2item
  18. JAK 13item
  19. Topoisomerases 1 item
  20. ErbB 1 item
  21. LRRK2 1 item
  22. COX 1 item
  23. Hck 1 item
  24. MNK 1 item
  25. PP4 1 item
  26. c-RET 1 item
  27. VEGFR3/FLT4 1 item
  28. NTRK1/TRKA 1 item
  29. CSF-1R/c-Fms 1 item
  30. LOX 1 item
  31. Adenylyl cyclase 1 item
  32. Quinone reductase 1 item
  33. Histone Acetyltransferases (HATs) 1 item
  34. Lck 1 item
  35. FGR 1 item
  36. YES 1 item
  37. Fyn 1 item
  38. ARG 1 item
  39. SK 1 item
Reported Experiments
  1. Animal Experiments 39item
  2. Cell Experiments 37item
Related Disease
  1. Acute Myelogenous Leukemia 1 item
  2. Acute Myeloid Leukemia 4item
  3. Breast Cancer 5item
  4. Cancer 31item
  5. Cervical Cancer 1 item
  6. Colon Cancer 4item
  7. Colorectal Cancer 2item
  8. Diabetes 1 item
  9. Glioblastoma 1 item
  10. Glioma 1 item
  11. HIV Infections 1 item
  12. Immunological Diseases 1 item
  13. Inflammatory Bowel Disease 1 item
  14. Leukemia 1 item
  15. Lung Cancer 3item
  16. Lymphoma 2item
  17. Melanoma 1 item
  18. Multiple Myeloma 1 item
  19. Myelofibrosis 1 item
  20. Ovarian Cancer 2item
  21. Pancreatic Cancer 3item
  22. Prostate Cancer 3item
  23. Psoriasis 1 item
  24. Renal Cell Carcinoma 1 item
  25. Rheumatoid Arthritis 3item
  26. Thyroid Cancer 1 item